Gene · 84126
Papers1,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCPH1 and DNA Damage Response Pathway Genes as Candidate Susceptibility Loci in Hereditary Breast Cancer. | Diagnostics (Basel) | 2026 | 42793752 | PubTator, text mining | PubMed |
| Capturing ATR-ATRIP in the act of activation. | Nat Struct Mol Biol | 2026 | 42754754 | PubTator, text mining | PubMed |
| Mechanistic insights into phosphorylation-driven activation and therapeutic inhibition of human ATR-ATRIP. | Nat Struct Mol Biol | 2026 | 42754753 | PubTator, text mining | PubMed |
| SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA-PKcs/CHK1 replicative checkpoint to inhibit cell growth in non-small cell lung cancer. | Mol Oncol | 2026 | 42751865 | PubTator, text mining | PubMed |
| New Roles of Chk1 in Spindle Formation and Genome Integrity. | Biology (Basel) | 2026 | 42510653 | PubTator, text mining | PubMed |
| Structural mechanism of TOPBP1 activating the ATR-ATRIP replication checkpoint kinase. | Nat Struct Mol Biol | 2026 | 42493622 | PubTator, text mining | PubMed |
| Identification of dual-targeting PROTACs for ataxia telangiectasia and RAD3-related and aurora kinase A as chemo-sensitizers for leukemia cells. | Eur J Med Chem | 2026 | 42462624 | PubTator, text mining | PubMed |
| Library-based, multiplexed strategy for mapping protein interaction networks via crosslinking. | BMC Biotechnol | 2026 | 42304341 | PubTator, text mining | PubMed |
| Germline ATRIP variants and the risk of ovarian cancer. | Genet Med | 2026 | 42118082 | PubTator, text mining | PubMed |
| An updated view on lagging strand DNA replication: implications for the replication stress response. | Cell Cycle | 2026 | 41865289 | PubTator, text mining | PubMed |
| β-tubulin phosphorylation by Chk1 is required for normal spindle formation during cell division. | Commun Biol | 2026 | 41844775 | PubTator, text mining | PubMed |
| Dysregulation of the DNA damage response by phosphorothioate antisense oligonucleotides. | Nat Commun | 2026 | 41760661 | PubTator, text mining | PubMed |
| Comprehensive Investigation of a Novel Schiff Base: Synthesis, Anticancer Efficacy, Gene Expression Profiling, and Computational Analyses. | Pharmaceuticals (Basel) | 2026 | 41754872 | PubTator, text mining | PubMed |
| Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade. | J Natl Cancer Cent | 2026 | 41738042 | PubTator, text mining | PubMed |
| Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer. | Nat Commun | 2026 | 41735312 | PubTator, text mining | PubMed |
| Multi-omics and machine learning-based profiling of severity signatures in Mycoplasma pneumoniae infection in children. | iScience | 2026 | 41732270 | PubTator, text mining | PubMed |
| Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model. | J Transl Int Med | 2026 | 41727958 | PubTator, text mining | PubMed |
| ssDNA-PLA, a proximity ligation assay to interrogate DNA damage response proteins involved in homologous recombination. | Biol Methods Protoc | 2026 | 41710294 | PubTator, text mining | PubMed |
| Clinicopathological and functional evaluation of replication protein A in epithelial ovarian cancers: A target validation study. | Transl Oncol | 2026 | 41702233 | PubTator, text mining | PubMed |
| RPA-independent activation of the ATR/CHK1 pathway. | Proc Natl Acad Sci U S A | 2026 | 41628322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84126/papers